Transparency fundraising2020-02-21T18:03:41+00:00

Collaborative Partnership Guidelines

Working with the pharmaceutical and biotech industries.

Download the PDF


Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide. Their mission is to discover new ways to improve and extend people’s lives. Their vision is to be a trusted leader in changing the practice of medicine.

Commitment to patients and caregivers:

  • Strong values define their culture and help them execute the Novartis strategy in line with their mission and vision.

  • Their strategy is to use science-based innovation to deliver better patient outcomes. They aim to lead in growing areas of healthcare.


With synergistic strengths and unique innovation, they offer better healthcare and accessible treatment to millions worldwide.

  • Teva was established in 1901, their global headquarters are based in Israel.

  • Number 1 in generics worlwide

  • 120 billion tablets and capsules produced each year

  • 80 number of countries in which they operate worldwide


Allergan, based in Dublin, Ireland, is a leading, global and bold pharmaceutical company. Allergan focuses on the development, manufacture and marketing of branded pharmaceuticals, medical devices, biological, surgical and regenerative products for patients around the world.

  • We are Bold for Life. This phrase inspires us to do what is best for our customers and patients. We are committed and connected. To our customers and their patients. To each other. To the world around us. Each of us has a vital role to play. Teamwork and partnership make us stronger. Better. Bolder.

  • We actively contribute to economic, environmental and philanthropic initiatives that improve health and the quality of life in our communities. Learn more about our commitment to social responsibility.


Lilly is an American global pharmaceutical company with headquarters located in Indianapolis, Indiana, in the United States. The company also has offices in Puerto Rico and 17 other countries.

  • Promise : Lilly unites caring with discovery to make life better for people around the world.

  • Mission: We make medicines that help people live longer, healthier, more active lives.

  • Vision : We will make a significant contribution to humanity by improving global health in the 21st century.

  • Values: Integrity, excellence and respect for people.


Curelator Headache guides individuals with migraine headaches to identify their personal triggers, dismiss irrelevant factors, and discover protectors.

  • Our mission is to improve health outcomes in chronic diseases by:

  • Measuring the impact of environmental, emotional and dietary factors including medications

  • Developing therapeutic pathways – for each individual patient


The Grünenthal Group is an entrepreneurial, science-based pharmaceutical company specialized in pain, gout, and inflammation.

Their ambition is to deliver four to five new products to patients in diseases with high unmet medical need by 2022 and become a €2 billion company. They are a fully integrated research & development company with a long track record of bringing innovative pain treatments and state-of-the-art technologies to patients. By sustainably investing in our R&D above the industrial average, they are strongly committed to innovation.

  • Building on our research and development expertise in pain we turn our attention to new therapeutic approaches and special indications to shape the field and transform the future of pain – targeting focused indications (niches), precision medicine (e.g. non-responder) and disease modification (e.g. reversal of chronification).

  • We are searching for new assets/ projects beyond pain and are highly flexible with regard to therapeutic focus. We develop solutions for small or orphan indications with a high unmet medical need for patients with severe diseases.

  • Another important pillar is the exploration of new technologies and devices. Building on our NTE expertise, we are investigating new platform technologies and devices in pain and beyond to provide therapeutic alternatives to the patient

We and our partners use cookies, to collect browsing data to give you the best online experience and to personalize the content, play multimedia content, interact with social networks and perform browsing analytics. If you continue browsing we understand you accept the use of such technology. For more information visit our cookies policy Find out more

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.